KRAS and non-small cell lung carcinoma: KRAS mutations are present in approximately 20–25% of NSCLC cases, with a higher prevalence in patients with adenocarcinoma compared to those with other histological subtypes, suggesting a strong correlation with tobacco exposure [55].